Histamine H2 receptor-mediated cyclic AMP formation in human platelets

Area of Science:

• Biochemistry
• Pharmacology
• Hematology

Background:

• Platelets play a crucial role in hemostasis and thrombosis.
• Cyclic AMP (cAMP) is a key intracellular second messenger regulating platelet activation.
• Histamine is a biogenic amine with diverse physiological roles.

Purpose of the Study:

• To investigate the effect of histamine on cyclic AMP (cAMP) levels in human platelets.
• To determine the specific histamine receptor subtype involved in this effect.
• To assess the functional consequences of histamine-induced cAMP accumulation on platelet activity.

Main Methods:

• Human platelets were incubated with varying concentrations of histamine.
• Cyclic AMP (cAMP) levels were measured using established biochemical assays.
• Pharmacological agents, including H1 and H2 antagonists and adrenergic antagonists, were used to identify receptor involvement.
• Platelet release reactions were assessed to evaluate functional changes.

Main Results:

• Histamine induced a dose-dependent accumulation of cyclic AMP (cAMP) in human platelets, peaking at approximately 10 microM.
• The histamine-induced cAMP increase was specifically blocked by the H2 receptor antagonist cimetidine.
• Neither H1 antagonists nor alpha- or beta-adrenergic antagonists affected the histamine response.
• A reduction in platelet release reaction was observed, consistent with the functional role of cAMP.

Conclusions:

• Histamine stimulates cyclic AMP (cAMP) accumulation in human platelets primarily through the activation of H2 receptors.
• This histamine-mediated cAMP increase is associated with a depression of platelet function, specifically reducing the platelet release reaction.
• The findings identify a novel signaling pathway involving histamine and H2 receptors that modulates human platelet activity.